Mefloquine in infants and young children

Annals of Tropical Paediatrics

Volumn 16, Issue 4, 1996, Pages 281-286

  Luxemburger, Christine ^a,b   Price, Richard N ^a,b   Nosten, Francois ^a,b,d   Ter Kuile, Feiko O ^a,c   Chongsuphajaisiddhi, T ^b   White, Nicholas J ^a,b,d  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; MEFLOQUINE;

ARTICLE; CHILD; DIARRHEA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; NAUSEA; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; VERTIGO; VOMITING;

EID: 0029951303     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724936.1996.11747839     Document Type: Article

References (18)

1. Palmer KJ, Holliday SM, Brogden RN. Mefloquine: A review of its antimalarial activity, pharmacokinetic properties, and therapeutic efficacy. Drugs 1993; 45:430-75.
2. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341:848-51
3. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341:1299-1303.
4. Nosten F, Luxemburger C, ter Kuile FO, et al. Treatment of multidrug-resistant P. falciparum malaria with 3-day artesunate mefloquine combination. J Infect Dis 1994; 170:971-7.
5. Price RN, Nosten F, Luxemburger C, et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89:523-7.
6. ter Kuile FO, Luxemburger C, Nosten F, et al. Mefloquine treatment of acute falciparum malaria; a prospective study of non-serious adverse effects in 3673 patients. Bull WHO (in press).
7. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991; 45:86-91.
8. Luxemburger C, Nosten F, ter Kuile F, Frejacques L, Chongsuphajaisiddhi T, White NJ. Mefloquine for multidrug-resistant malaria. Lancet 1991; 338:1268.
9. Phillips-Howard PA, ter Kuile FO. CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Safety 1995; 12:370-83.
10. Slutsker LM, Khoromana CO, Payne D, et al. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull WHO 1990; 68:53-9.
11. Sowunmi A, Salako LA, Walker O, Ogundahunsi AT. Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Trans R Soc Trop Med Hyg 1990; 84:761-4.
12. Sowunmi A, Oduola AMJ. Open comparison of mefloquine, mefloquine-sulfadoxine-pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children. Trans R Soc Trop Med Hyg 1995; 89:303-5.
13. Luxemburger C, Kyaw Lay Thwai, White NJ, et al. The epidemiology of malaria in a Karen population on the Thai-Burmese border. Trans R Soc Trop Med Hyg 1996; 90:105-11.
14. ter Kuile FO, Nosten F, Thieren M, et al. High dose mefloquine in the treatment of multi-drug resistant falciparum malaria. J Infect Dis 1992; 166:1393-9.
15. ter Kuile FO, Dolan G, Nosten F, et al. Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 1993; 341:1044-9.
16. Luxemburger C, ter Kuile FO, Nosten F, et al. Single day mefloquine-artesunate combination in the treatment of multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1994; 88:213-17.
17. World Health Organization. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990; 84(suppl. 2):1-65.
18. ter Kuile FO, Luxemburger C, Nosten F, et al. Predictors of mefloquine treatment failure; a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89:660-4.